Ionis Pharmaceuticals Ownership | Who Owns Ionis Pharmaceuticals?
Ionis Pharmaceuticals Ownership Summary
Ionis Pharmaceuticals is owned by 104.99% institutional investors, 0.77% insiders. Fmr is the largest institutional shareholder, holding 15.04% of IONS shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.62% of its assets in Ionis Pharmaceuticals shares.
IONS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Ionis Pharmaceuticals | 104.99% | 0.77% | -5.75% |
| Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
| Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 21.89M | 15.04% | $1.04B |
| Vanguard group | 13.85M | 9.51% | $659.89M |
| T. rowe price investment management | 12.64M | 8.68% | $602.41M |
| Blackrock | 10.32M | 7.09% | $491.90M |
| Bellevue group | 8.26M | 5.68% | $393.69M |
| Wellington management group llp | 6.57M | 4.51% | $313.07M |
| State street | 4.19M | 2.88% | $199.72M |
| Price t rowe associates inc /md/ | 3.93M | 2.70% | $187.51M |
| Tweedy, browne | 3.45M | 2.37% | $164.65M |
| Bvf inc/il | 3.19M | 2.19% | $151.86M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tweedy, browne | 3.45M | 7.57% | $164.65M |
| Bellevue group | 8.26M | 6.40% | $393.69M |
| Bvf inc/il | 3.19M | 4.26% | $151.86M |
| Orion investment | 218.57K | 4.15% | $10.42M |
| Sector gamma as | 170.00K | 3.03% | $8.10M |
| Great point partners | 330.00K | 3.01% | $15.73M |
| Privium fund management b.v. | 247.27K | 2.85% | $11.16M |
| Deep track capital, lp | 2.00M | 2.85% | $95.32M |
| Sicart associates | 185.82K | 2.32% | $6.50M |
| Cutter capital management, lp | 160.17K | 2.30% | $7.63M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Capital world investors | 2.25M | 0.02% | 1.41M |
| Artisan partners limited partnership | 1.67M | 0.12% | 1.25M |
| Norges bank | 1.02M | 0.01% | 1.02M |
| Wellington management group llp | 6.57M | 0.06% | 873.11K |
| Bvf inc/il | 3.19M | 4.26% | 757.76K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Clearbridge investments | 2.16M | 0.08% | -2.31M |
| Pictet asset management sa | 2.41M | 0.13% | -1.33M |
| Macquarie group | 1.87M | 0.10% | -1.33M |
| Balyasny asset management | - | - | -1.08M |
| T. rowe price investment management | 12.64M | 0.38% | -677.43K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 1.02M | 0.01% | 1.02M | $48.58M |
| Great point partners | 330.00K | 3.01% | 330.00K | $15.73M |
| Logos global management lp | 300.00K | 1.15% | 300.00K | $14.30M |
| Integral health asset management | 250.00K | 1.13% | 250.00K | $11.91M |
| Orion investment | 218.57K | 4.15% | 218.57K | $10.42M |
Sold Out
| Holder | Change |
|---|---|
| Assetmark | -1.00 |
| Bokf, na | -7.00 |
| Rosenberg matthew hamilton | -20.00 |
| Thurston, springer, miller, herd & titak | -20.00 |
| Concourse financial group securities | -26.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 378 | 0.27% | 156,005,896 | 8.92% | 104 | 1.08% | 182 | 3.41% | 106 | -17.83% |
| Jun 30, 2024 | 375 | -2.60% | 143,227,487 | 1.66% | 98 | 1.02% | 176 | 2.92% | 127 | 0.79% |
| Mar 31, 2024 | 385 | 1.05% | 140,888,836 | -0.88% | 98 | 1.00% | 171 | -9.04% | 126 | 5.88% |
| Dec 31, 2023 | 381 | 17.59% | 142,138,886 | 2.61% | 99 | 1.06% | 188 | 38.24% | 119 | 10.19% |
| Sep 30, 2023 | 324 | 3.18% | 138,518,212 | 2.21% | 96 | 1.08% | 136 | 3.03% | 108 | -1.82% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 10.45M | 6.62% | 145.25K |
| Fidelity Growth Compy Commingled Pl O | 9.71M | 6.16% | 90.97K |
| BB Biotech AG Ord | 7.85M | 4.98% | -360.00K |
| Fidelity Growth Company Fund | 7.45M | 4.72% | -76.38K |
| Vanguard Health Care Inv | 5.73M | 3.64% | 1.54M |
| T. Rowe Price US Mid-Cap Growth Equity | 5.28M | 3.34% | -22.90K |
| T. Rowe Price Mid-Cap Growth | 5.28M | 3.34% | - |
| Vanguard Total Stock Mkt Idx Inv | 4.79M | 3.03% | 329.77K |
| American Funds SMALLCAP World A | 4.06M | 2.57% | 1.89M |
| Vanguard Small Cap Index | 3.82M | 2.42% | 239.16K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 16, 2025 | Swayze Eric | EVP Research | Sell | $719.40 |
| Jan 16, 2025 | Swayze Eric | EVP Research | Sell | $234.96K |
| Jan 16, 2025 | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | $213.89K |
| Jan 16, 2025 | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | $241.63K |
| Jan 16, 2025 | Monia Brett P | Chief Executive Officer | Sell | $1.09M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | 2 | 4 |
| 2024 Q3 | - | 6 |
| 2024 Q2 | - | 9 |
| 2024 Q1 | - | 33 |
| 2023 Q4 | - | 21 |
IONS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools